We sought to determine the frequency of aberrant promoter methylation and of chromosome 10 deletion and copy number alterations affecting the MGMT locus and to examine how those genomic alterations correlated with transcript levels in high-grade gliomas. This evidence concerns the gene MGMT and glioma.